Mucocutaneous Leishmaniasis Overview
20 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the most serious form of leishmaniasis?

  • Zoonotic leishmaniasis
  • Cutaneous leishmaniasis
  • Visceral leishmaniasis (correct)
  • Mucocutaneous leishmaniasis
  • Which of the following factors is NOT associated with leishmaniasis?

  • Population displacement
  • Obesity (correct)
  • Poor housing
  • Weak immune system
  • Why is the rate of Leishmania-HIV co-infection particularly high in specific regions such as Brazil and Ethiopia?

  • Increased agricultural practices
  • Poorer socioeconomic conditions (correct)
  • Higher urbanization rates
  • Greater access to healthcare
  • What role do environmental changes play in leishmaniasis?

    <p>They can increase transmission rates</p> Signup and view all the answers

    What is the estimated annual incidence of new leishmaniasis cases?

    <p>700,000 to 1 million</p> Signup and view all the answers

    Which of the following treatments is effective in reducing the development of leishmaniasis in co-infected patients?

    <p>Antiretroviral treatment</p> Signup and view all the answers

    What is the primary vector for the transmission of Leishmania parasites?

    <p>Sandflies</p> Signup and view all the answers

    The cutaneous form of leishmaniasis is characterized by what?

    <p>Skin sores and lesions</p> Signup and view all the answers

    What factor significantly influences the likelihood of developing disease after infection with Leishmania parasites?

    <p>Nutritional status</p> Signup and view all the answers

    Which type of leishmaniasis is considered the most common?

    <p>Cutaneous leishmaniasis</p> Signup and view all the answers

    What is the primary method of diagnosis for mucocutaneous leishmaniasis?

    <p>Microscope identification of amastigotes</p> Signup and view all the answers

    In which regions are over 90% of mucocutaneous leishmaniasis cases reported?

    <p>Bolivia, Brazil, Ethiopia, Peru</p> Signup and view all the answers

    Which of the following treatments is NOT commonly used for mucocutaneous leishmaniasis?

    <p>Azithromycin</p> Signup and view all the answers

    Which sandfly species is primarily responsible for transmitting mucocutaneous leishmaniasis?

    <p>Phlebotomus papatasi</p> Signup and view all the answers

    How long can a patient remain infectious to sandflies after being infected with mucocutaneous leishmaniasis?

    <p>Few months to 2 years</p> Signup and view all the answers

    What is a common characteristic of a classic Leishmania major lesion?

    <p>Volcanic appearance with rolled edges</p> Signup and view all the answers

    What can potentially interfere with the intra-dermal leishmanin test in diagnosing leishmaniasis?

    <p>Immuno-suppression</p> Signup and view all the answers

    Which species of Leishmania is NOT a known infectious agent for mucocutaneous leishmaniasis in the Eastern hemisphere?

    <p>Leishmania braziliensis</p> Signup and view all the answers

    Which of the following is a recommended method of control for mucocutaneous leishmaniasis?

    <p>Quarantine and immunization of contacts</p> Signup and view all the answers

    What is the typical incubation period for mucocutaneous leishmaniasis?

    <p>At least a week to several months</p> Signup and view all the answers

    Study Notes

    Mucocutaneous Leishmaniasis

    • Characterized by partial or complete destruction of nasal, oral, and throat mucous membranes.
    • Predominantly found in Bolivia, Brazil, Ethiopia, and Peru (over 90% of cases).
    • Classic lesion (Leishmania major) in Iraq shows a volcanic appearance with raised edges.
    • Diagnosis methods:
      • Microscopic identification of amastigotes (non-motile, intracellular forms) in stained lesion samples.
      • Intradermal Montenego test (leishmanin antigen) is often positive in established disease, less useful in early or immunocompromised cases.
      • Serological tests (IFA or ELISA).
    • Infectious agents:
      • Eastern hemisphere: Leishmania tropica, Leishmania major, Leishmania aethiopica.
      • Western hemisphere: Leishmania braziliensis, Leishmania mexicana.
    • Reservoir hosts: Diverse, including humans, wild rodents, and domestic dogs.
    • Incubation period: At least one week, up to several months.
    • Transmission:
      • Bite of infected female phlebotomine sandflies (e.g., P. papatasi, P. sergenti).
      • Rarely, through blood transfusion.
    • Communicability: Not directly person-to-person. Infectious to sandflies while parasites are in lesions (untreated cases can last a few months to 2 years).
    • Susceptibility: General. Possible life-long immunity after healing from L. tropica and L. major, but not against other Leishmania species.
    • Control methods:
      • Preventive: Similar to visceral leishmaniasis prevention.
      • Patient, contact, and environmental control:
        • Reporting to health authorities.
        • Isolation, disinfection, and contact investigation/quarantine (not applicable): Interrupt transmission cycle practically.
        • Investigate contacts and infection source.
      • Specific treatment:
        • Antimony-containing compounds:
          • Meglumine antimoniate
          • Sodium stibogluconate
        • Other drugs:
          • Amphotericin B
          • Ketoconazole
          • Miltefosine
          • Paromomycin
          • Pentamidine
    • Epidemic measures:
      • Provide diagnostic/treatment facilities.
      • Control sandflies and mammalian reservoirs.
    • Leishmania-HIV coinfection:
      • High risk of full-blown disease, relapse, and mortality in coinfected patients.
      • Antiretroviral treatment reduces disease development, delays relapse, and improves survival.
      • High coinfection rates reported in Brazil, Ethiopia, and Bihar, India.

    Leishmaniasis Overview

    • Three main forms: Visceral (most serious), cutaneous, mucocutaneous.
    • Caused by Leishmania parasites transmitted by sandfly bites.
    • Impacts vulnerable populations due to malnutrition, displacement, poor housing, and weak immune systems.
    • Linked to environmental changes like deforestation, dam construction, irrigation, and urbanization.
    • Estimated 700,000-1,000,000 new cases annually.
    • Only a fraction of infected individuals develop the disease.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Explore the characteristics, diagnosis methods, and transmission of mucocutaneous leishmaniasis, a disease primarily affecting the mucous membranes. Learn about the different strains and geographical distribution of Leishmania species, as well as the diagnostic tests used to identify the infection. This quiz provides insights into the clinical manifestations and epidemiology of this disease.

    More Like This

    Use Quizgecko on...
    Browser
    Browser